Paris, France

Carole Sackur

USPTO Granted Patents = 10 


Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2004-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Carole Sackur: Innovator in Melanocortin Receptor Research

Introduction

Carole Sackur is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmacology, particularly in the development of novel compounds targeting melanocortin receptors. With a total of 10 patents to her name, her work has the potential to impact the treatment of various pathological disorders.

Latest Patents

Among her latest patents, Carole Sackur has developed pyrimido-benzimidazole derivatives that serve as agonists or antagonists of melanocortin receptors. This invention focuses on novel compounds that exhibit a strong affinity for specific melanocortin receptor sub-types, especially the MC4 receptors. These products are particularly promising for treating diseases associated with melanocortin receptors. Additionally, she has patented benzimidazole and imidazopyridine derivatives, which also show good affinity for melanocortin receptors. These derivatives are suitable for treating various pathological states and diseases involving these receptors, and her patents include pharmaceutical compositions containing these innovative products.

Career Highlights

Carole has worked with notable companies such as Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. Her experience in these organizations has allowed her to further her research and development efforts in the pharmaceutical industry.

Collaborations

Throughout her career, Carole has collaborated with esteemed colleagues, including Lydie Francine Poitout and Pierre Roubert. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Carole Sackur is a distinguished inventor whose work in melanocortin receptor research has the potential to lead to significant advancements in medical treatments. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…